SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-18-016307
Filing Date
2018-03-09
Accepted
2018-03-09 14:45:02
Documents
2
Group Members
DANIEL K. TURNER, IIIMONTREUX EQUITY MANAGEMENT V, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a18-7946_1sc13g.htm SC 13G 114641
2 EX-1 a18-7946_1ex99d1.htm EX-99.1 11521
  Complete submission text file 0001104659-18-016307.txt   127855
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Subject) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-84019 | Film No.: 18679701
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
Montreux Equity Partners V, L.P. (Filed by) CIK: 0001548152 (see all company filings)

IRS No.: 455113281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G